191 related articles for article (PubMed ID: 2885574)
1. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification.
Venter DJ; Tuzi NL; Kumar S; Gullick WJ
Lancet; 1987 Jul; 2(8550):69-72. PubMed ID: 2885574
[TBL] [Abstract][Full Text] [Related]
2. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
[TBL] [Abstract][Full Text] [Related]
3. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
[TBL] [Abstract][Full Text] [Related]
4. c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue.
McCann A; Johnston PA; Dervan PA; Gullick WJ; Carney DN
Ir J Med Sci; 1989 Jun; 158(6):137-40. PubMed ID: 2570047
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
Wright C; Angus B; Nicholson S; Sainsbury JR; Cairns J; Gullick WJ; Kelly P; Harris AL; Horne CH
Cancer Res; 1989 Apr; 49(8):2087-90. PubMed ID: 2564806
[TBL] [Abstract][Full Text] [Related]
6. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.
Falck VG; Gullick WJ
J Pathol; 1989 Oct; 159(2):107-11. PubMed ID: 2572685
[TBL] [Abstract][Full Text] [Related]
9. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE
Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA; Marques LA; Torloni H; Brentani MM
Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
12. NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue.
Corbett IP; Henry JA; Angus B; Watchorn CJ; Wilkinson L; Hennessy C; Gullick WJ; Tuzi NL; May FE; Westley BR
J Pathol; 1990 May; 161(1):15-25. PubMed ID: 1973458
[TBL] [Abstract][Full Text] [Related]
13. c-erbB-2 amplification and overexpression in breast cancer: evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry.
Dawkins HJ; Robbins PD; Sarna M; Carrello S; Harvey JM; Sterrett GF
Pathology; 1993 Apr; 25(2):124-32. PubMed ID: 8103591
[TBL] [Abstract][Full Text] [Related]
14. Expression of the c-erbB-2 proto-oncogene protein in human breast cancer.
Gullick WJ
Recent Results Cancer Res; 1989; 113():51-6. PubMed ID: 2569220
[TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.
Sasaki K; Tomita Y; Azuma M; Shida S; Simizu B
Gastroenterol Jpn; 1992 Apr; 27(2):172-8. PubMed ID: 1577221
[TBL] [Abstract][Full Text] [Related]
16. HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies.
Arnaout AH; Dawson PM; Soomro S; Taylor P; Theodorou NA; Feldmann M; Fendly BM; Shepard HM; Shousha S
J Clin Pathol; 1992 Aug; 45(8):726-7. PubMed ID: 1357006
[TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
Hynes NE
Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 oncoprotein expression in primary human tumors.
McCann A; Dervan PA; Johnston PA; Gullick WJ; Carney DN
Cancer; 1990 Jan; 65(1):88-92. PubMed ID: 2403483
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
